ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022

Agilent Technologies Inc. (NYSE: A) today announced new LC/MS and GC/MS quadrupole mass spectrometers which will be on show at the 70th ASMS Conference on Mass Spectrometry and Allied Topics being held June 5 - 9, 2022 in Minneapolis, Minnesota.

The Agilent 6475 triple quadrupole LC/MS system, 5977C GC/MSD, plus the 7000E GC/TQ and the 7010C GC/TQ represent the latest revolution in Agilent’s 50-plus year history in mass spectrometry. The new LC/TQ and GC/TQ products offer built-in instrument intelligence to simplify lab operations. The new GC/SQ and GC/TQ products with the HydroInert source help customers overcome key performance challenges with Hydrogen carrier gas.

“These new innovative and intelligent LC/MS and GC/MS systems are designed to make the lives of our customers easier,” said Sudharshana Seshadri, vice president and general manager of Agilent’s Mass Spectrometry Division. “Raising the level of built-in instrument intelligence and a higher level of instrument diagnostics maximizes system uptime, allows proactive scheduling of routine maintenance, and minimizes the impact on lab productivity by allowing operators to focus on their analyses rather than on their instruments.”

For routine quantitative analysis, the Agilent 6475 triple quadrupole LC/MS system is the next evolution in sensitive, rugged, robust mass spectrometer. The 6475 incorporates intelligent reflex, an automated sample reinjection function that intelligently ‘reflexes’ to specific analysis conditions providing immediate validation of results, further improving the speed of analysis and reducing operator involvement. Coupled with 6475, the latest revision of MassHunter Acquisition 12.0 enables data integrity consistent with the regulatory requirements as defined in 21 CFR Part 11 and Annex 11, a key requirement for pharmaceutical and biopharmaceutical manufacturing customers.

The Agilent 5977C GC/MSD system is the latest in trusted single quadrupole GC/MS instruments. The introduction of HydroInert source in the 5977C allows customers to explore hydrogen as a viable alternative to helium as a carrier gas for GC/MS with minimal impact on performance and minimizing dependence on helium as a non-renewable resource.

Also introduced were the Agilent 7000E and 7010C triple quadrupole GC/MS systems, the latest iterations of the popular GC/MS family used across many market segments. The 7000E GC/TQ is a robust and reliable instrument providing optimum operational efficiency for high-throughput labs. The 7010C GC/TQ has been designed to address the most challenging analyses, providing the lowest detection limits to the attogram level.

Additionally, through Agilent’s partnership with My Green Lab, each of these instruments has been independently audited for their Accountability, Consistency, and Transparency (ACT) Label, which provides a baseline and framework for continuous improvement on how Agilent products are impacting the environment. ACT makes it easier for customers to choose more sustainable products for their labs.

ASMS attendees are invited to visit Agilent’s Exhibition Booth #401 at the Minneapolis Convention Center and to spend time at the Agilent Hospitality Suite at the Hilton Minneapolis Hotel Grand Ballroom ABC on Monday, Tuesday, and Wednesday evenings from 8:00–11:00 p.m. Visitors will be able to view the latest Agilent mass spec suite of products and speak with Agilent subject matters experts to learn how these innovative and intelligent systems improve the precision and reproducibility of mass spec analyses.

Breakfast seminars will be held Monday, Tuesday, and Wednesday mornings in the Agilent Hospitality Suite from 7:00–8:15 a.m., with engaging session titles such as Oligo to Go, The Head and Heart of Routine Analysis, and Omics Remix.

Agilent is a corporate member of ASMS and a co-sponsor of the annual event. Follow Agilent at ASMS on Twitter, using the conference hashtag: #ASMS2022.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.